SCHEMBL16257512

SCHEMBL16257512

CCOC(=O)c1ncnc(Nc2ccc3ccc(OC)cc3c2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.48
ERBB3 P21860 1/20 0.48
DHODH Q02127 3/20 0.46
MAPT P10636 5/20 0.45
KDM4E B2RXH2 4/20 0.45
TP53 P04637 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 2/20 0.45
NPSR1 Q6W5P4 1/20 0.44
SHMT2 P34897 1/20 0.43
FGFR1 P11362 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
TARBP2 Q15633 1/20 0.42
PDCD4 Q53EL6 1/20 0.42
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42
CSNK2A1 P68400 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257591 0.98 EGFR (0.50) EGFRERBB3DHODHMAPTKDM4E
SCHEMBL16257511 0.89 DHODH (0.55) EGFRERBB3DHODHMAPTKDM4E
SCHEMBL16257513 0.87 CSF1R (0.45) EGFRERBB3MAPTKDM4ENPSR1
SCHEMBL16257608 0.85 HPGD (0.47) EGFRDHODHMAPTKDM4ETP53
SCHEMBL16257609 0.84 CSF1R (0.47) EGFRERBB3MAPTKDM4ENPSR1
SCHEMBL12180012 0.78 CCR2 (0.48) ALDH1A1HPGDPOLB
SCHEMBL16257575 0.78 MAPT (0.48) EGFRMAPTKDM4ETP53SMN1; SMN2
SCHEMBL12180017 0.76 CCR2 (0.49) ALDH1A1HPGDMEN1KMT2APOLB
SCHEMBL12179967 0.74 DHODH (0.52) DHODHTP53LMNA
SCHEMBL16257589 0.73 CSNK2A2 (0.48) EGFRDHODHMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed